John M. Reher is the founder, managing director, and general partner of the Brain Trust Accelerator Fund. See sector focus and contact routes.
John M. Reher is the founder, managing director, and general partner of the Brain Trust Accelerator Fund, a venture capital firm he established in 2006 to invest in early-stage medical companies addressing brain-related diseases. His investment thesis focuses exclusively on the brain disease sector, targeting translational-stage companies developing diagnostics and treatments for neurological disorders across the United States. The fund has executed tracked deals including a $20.0 million Series B investment in Chase Therapeutics, though specific typical check sizes and lead/follow behavior are not publicly detailed. Notable portfolio companies include NeuroTherapia, which received a Series B investment in August 2024, as well as previously acquired firms Amnestix and Chase Pharmaceuticals. Reher brings over 35 years of venture capital experience, having previously co-founded Medicus Venture Partners and served as the founding president of Accelerate Brain Cancer Cure, Inc.. A distinctive aspect of his approach is directing a portion of the fund’s carried interest to brain disease charities that provide deal flow and advisory services, integrating philanth
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Burlingame.
Investors like John M. Reher · Full investor directory · Investor access · Company funding database